Serum paraoxonase activity, high-sensitivity C-reactive protein, and lipoprotein disturbances in end-stage renal disease patients on long-term hemodialysis.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Clinical Lipidology

• Publication date

  2008-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jacl.2007.12.003PMID 21291714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.

  2007cited by this paper
• Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance.

  2007cited by this paper
• B vitamins for the prevention of vascular disease: insufficient evidence to justify treatment.

  2007cited by this paper
• Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP.

  2007cited by this paper
• C-reactive Protein Is a Strong Predictor of Mortality in Hemodialysis Patients

  2006cited by this paper
• Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.

  2006cited by this paper
• Relationship Between Homocysteine and Mortality in Chronic Kidney Disease

  2006cited by this paper
• The story of PON1: how an organophosphate-hydrolysing enzyme is becoming a player in cardiovascular medicine.

  2006cited by this paper
• Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.

  2006cited by this paper
• The Catalytic Histidine Dyad of High Density Lipoprotein-associated Serum Paraoxonase-1 (PON1) Is Essential for PON1-mediated Inhibition of Low Density Lipoprotein Oxidation and Stimulation of Macrophage Cholesterol Efflux*

  2006cited by this paper
• Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I Published, JLR Papers in Press, December 3, 2005.

  2006cited by this paper
• [High sensivity C-reactive protein as a complement to classical methods in the evaluation of coronary event's risk].

  2006cited by this paper
• [Lipid profile in maintenance haemodialysis].

  2005cited by this paper
• Elevated homocysteine levels in patients with end-stage renal disease.

  2005cited by this paper
• Profil lipidique dans l’insuffisance rénale chronique au stade d’hémodialyse

  2005cited by this paper
• Homocysteine in uraemia--a puzzling and conflicting story.

  2005cited by this paper
• Serum paraoxonase activity in uremic predialysis and hemodialysis patients.

  2004cited by this paper
• The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels.

  2004cited by this paper
• Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients.

  2003cited by this paper
• Oxidative stress in end-stage renal disease: an emerging threat to patient outcome.

  2003cited by this paper
• Increased Levels of Low-Density Lipoprotein Oxidation in Patients with Familial Hypercholesterolemia and in End-Stage Renal Disease Patients on Hemodialysis

  2003cited by this paper
• Lipolytically Modified Triglyceride-Enriched HDLs Are Rapidly Cleared From the Circulation

  2002cited by this paper
• C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients.

  2002cited by this paper
• C-reactive protein and cardiovascular disease in peritoneal dialysis patients.

  2002cited by this paper
• Renal cortical thickness and PON1 activity both decrease in chronic renal failure.

  2002cited by this paper
• HDL3-related decreased serum paraoxonase (PON) activity in uremic patients: comparison with the PON1 allele polymorphism.

  2002cited by this paper
• Modulation of C-Reactive Protein-Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis Drugs

  2001cited by this paper
• C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages: Implications for Atherosclerosis

  2001cited by this paper
• Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia.

  2001cited by this paper
• An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease.

  2001cited by this paper
• Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment.

  2001cited by this paper
• Elevated plasma F2-isoprostanes in patients on long-term hemodialysis.

  2001cited by this paper
• Cardiovascular risk factors in patients with chronic renal failure maintained on hemodialysis or continuous ambulatory peritoneal dialysis.

  2001cited by this paper
• Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells

  2000cited by this paper
• [Is homocysteine a risk factor for coronary heart disease in patients with terminal renal failure?].

  2000cited by this paper
• Ist Homocystein ein Risikofaktor für das Vorliegen einer koronaren Herzkrankheit bei Patienten mit terminaler Niereninsuffizienz?

  2000cited by this paper
• Concentration of Lp(a) and other Apolipoproteins in Predialysis, Hemodialysis, Chronic Ambulatory Peritoneal Dialysis and Post-Transplant Patients

  2000cited by this paper
• C-Reactive Protein in the Arterial Intima: Role of C-Reactive Protein Receptor–Dependent Monocyte Recruitment in Atherogenesis

  2000cited by this paper
• Serum Paraoxonase Activity Changes in Uremic and Kidney-Transplanted Patients

  1999cited by this paper
• Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.

  1999cited by this paper
• Serum paraoxonase activity changes in uremic and kidney-transplanted patients.

  1999cited by this paper
• Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.

  1999cited by this paper
• Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.

  1998cited by this paper
• Decrease of serum paraoxonase activity in chronic renal failure.

  1998cited by this paper
• Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis?

  1998cited by this paper
• Homocysteine and vascular dysfunction.

  1997cited by this paper
• Serum paraoxonase activity is decreased in uremic patients.

  1996cited by this paper
• Myocardial injury: the acute phase response and lipoprotein metabolism.

  1993cited by this paper
• Lipoprotein metabolism and renal failure.

  1993cited by this paper
• Lipoprotein(a) Is an Independent Risk Factor for Cardiovascular Disease in Hemodialysis Patients

  1992cited by this paper
• Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein

  1991cited by this paper
• Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates.

  1990cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• Wide Web at:

  year unknowncited by this paper

• Serum Paraoxonase 1 and Gene Polymorphism (PON- Q192R) as an Atherosclerotic Marker in Chronic Kidney Disease Patients in Menoufia University Hospitals- Egypt

  2024cites this paper
• Clinical and Basic Cardiology

  2023cites this paper
• Paraoxonase 1 Activity and Renal Replacement Therapy for Chronic Renal Failure: A Meta-Analysis

  2023cites this paper
• Effect of Exercise Repetitions on Arylesterase Activity of PON1 in Plasma of Average-Trained Men—The Dissociation between Activity and Concentration

  2023cites this paper
• Effects of vitamin C supplementation on oxidative stress and serum paraoxonase/arylesterase activities in patients on long-term hemodialysis.

  2022cites this paper
• Proteomic Analysis of Human Serum from Patients with Chronic Kidney Disease

  2020cites this paper
• THE CARDIO - PROTECTIVE "PARAOXONASE - 1" AS A VALUABLE PROMISING TOOL IN DIAGNOSIS AND/OR ASSESSMENT OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES

  2018cites this paper
• Dialysis Method Alters the Expression of MicroRNA‐33a and Its Target Genes ABCA1, ABCG1 in THP‐1 Macrophages

  2014cites this paper
• Association of apolipoprotein E gene polymorphism with end-stage renal disease and hyperlipidemia in patients on long-term hemodialysis

  2014cites this paper
• Effect of GSTM1 and GSTT1 Deletions in the Development of Oxidative Stress in Children with Chronic Kidney Disease

  2013cites this paper
• Effect of the nutritional supplement ALAnerv® on the serum PON1 activity in post-acute stroke patients

  2013cites this paper
• Paraoxonase Enzyme Activity Is Enhanced by Zinc Supplementation in Hemodialysis Patients

  2012cites this paper
• Low High-Density Lipoprotein Cholesterol Is Not Responsible for Decreased Paraoxonase Activity in Chronic Renal Failure

  2012cites this paper
• Paraoxonase 1 in Chronic Kidney Failure

  2012cites this paper
• Altered inflammation, paraoxonase-1 activity and HDL physicochemical properties in obese humans with and without Prader-Willi syndrome

  2012cites this paper
• A hazardous link between malnutrition, inflammation and oxidative stress in renal patients.

  2012cites this paper
• Paraoxonase-1 ( PON 1 ) activity in patients with coronary artery diseases and in diabetic patients Étude de l ’ activité de la paraoxonase-1 ( PON 1 ) chez des patients coronariens et des patients diabétiques

  2011cites this paper
• Paraoxonase: Its antiatherogenic role in chronic renal failure

  2010cites this paper
• Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease – a perspective

  2010cites this paper
• Lipoprotein(a) in Chronic Renal Failure

  2009cites this paper